{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:46:50Z","timestamp":1793663210289,"version":"4.5.1"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00027","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T23:30:35Z","timestamp":1548718235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":110,"title":["Biomarkers in Spinal Cord Injury: Prognostic Insights and Future Potentials"],"prefix":"10.3389","volume":"10","author":[{"given":"Ahmed A.","family":"Albayar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Swiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Antar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouran","family":"Ouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Emara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem I.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/10790268.2016.1210925","article-title":"(SCI) Facts and figures at a glance","volume":"39","year":"2016","journal-title":"J Spinal Cord Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/emermed-2016-205780","article-title":"Presentation of neurogenic shock within the emergency department","volume":"34","author":"Taylor","year":"2017","journal-title":"Emerg Med J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/FOC.2008.25.11.E2","article-title":"Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon","volume":"25","author":"Rowland","year":"2008","journal-title":"Neurosurg Focus"},{"key":"B4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1212\/01.CON.0000461091.09736.0c","article-title":"Management of acute spinal cord injury","volume":"21","author":"Stein","year":"2015","journal-title":"Contin Lifelong Learn Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/BSD.0000000000000287","article-title":"Acute spinal cord injury","volume":"28","author":"Witiw","year":"2015","journal-title":"J Spinal Disord Tech."},{"key":"B6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/10790268.2008.11760744","article-title":"Early acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionals","volume":"31","year":"2008","journal-title":"J Spinal Cord Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.suc.2017.06.008","article-title":"Trauma: spinal cord injury","volume":"97","author":"Eckert","year":"2017","journal-title":"Surg Clin North Am."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/00007632-200112151-00002","article-title":"Epidemiology, demographics, and pathophysiology of acute spinal cord injury","volume":"26","author":"Sekhon","year":"2001","journal-title":"Spine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fncel.2016.00098","article-title":"Inflammogenesis of secondary spinal cord injury","volume":"10","author":"Anwar","year":"2016","journal-title":"Front Cell Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.expneurol.2007.05.014","article-title":"CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure","volume":"209","author":"Fitch","year":"2008","journal-title":"Exp Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/sc.2011.111","article-title":"Oxidative stress in spinal cord injury and antioxidant-based intervention","volume":"50","author":"Jia","year":"2012","journal-title":"Spinal Cord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/sc.2016.174","article-title":"The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood","volume":"55","author":"Hulme","year":"2017","journal-title":"Spinal Cord"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1089\/neu.2018.5935","article-title":"A review of clinical trials in spinal cord injury including biomarkers","volume":"2018","author":"Badhiwala","year":"2018","journal-title":"J Neurotraumaneu"},{"key":"B14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1515\/CCLM.2011.068","article-title":"Inflammatory and structural biomarkers in acute traumatic spinal cord injury","volume":"49","author":"Kwon","year":"2011","journal-title":"Clin Chem Lab Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"38718","DOI":"10.1038\/srep38718","article-title":"Parallel metabolomic profiling of cerebrospinal fluid and serum for identifying biomarkers of injury severity after acute human spinal cord injury","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e110885","DOI":"10.1371\/journal.pone.0110885","article-title":"CSF proteomics of secondary phase spinal cord injury in human subjects: perturbed molecular pathways post injury","volume":"9","author":"Sengupta","year":"2014","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm1595","article-title":"Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?","volume":"13","author":"Courtine","year":"2007","journal-title":"Nat Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1089\/neu.2009.1148","article-title":"Assessment of disability in patients with acute traumatic spinal cord injury: a systematic review of the literature","volume":"28","author":"Furlan","year":"2011","journal-title":"J Neurotra."},{"key":"B19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.7754\/Clin.Lab.2015.151103","article-title":"Advances in biomarkers in critical Ill polytrauma patients","volume":"62","author":"Papurica","year":"2016","journal-title":"Clin Lab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/sc.2014.26","article-title":"Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects","volume":"52","author":"Pouw","year":"2014","journal-title":"Spinal Cord"},{"key":"B21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1089\/089771503322385782","article-title":"Nervous tissue damage markers in cerebrospinal fluid after cervical spine injuries and whiplash trauma","volume":"20","author":"Gu\u00e9z","year":"2003","journal-title":"J Neurotr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/jnnp-2013-307454","article-title":"Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome","volume":"86","author":"Kuhle","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/sc.2011.184","article-title":"Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study","volume":"50","author":"Hayakawa","year":"2012","journal-title":"Spinal Cord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.bbrc.2005.08.252","article-title":"Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury","volume":"336","author":"Shaw","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"E823","DOI":"10.1097\/BRS.0000000000000654","article-title":"Diagnostic value of serum levels of GFAP, pNF-H, and NSE compared with clinical findings in severity assessment of human traumatic spinal cord injury","volume":"40","author":"Ahadi","year":"2015","journal-title":"Spine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1089\/neu.2009.1080","article-title":"Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury","volume":"27","author":"Kwon","year":"2010","journal-title":"J Neurotr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/neu.2016.4435","article-title":"Cerebrospinal fluid biomarkers to stratify injury severity and predict outcome in human traumatic spinal cord injury","volume":"34","author":"Kwon","year":"2017","journal-title":"J Neurotr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1227\/01.NEU.0000207967.91316.8D","article-title":"Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100beta","volume":"56","author":"Loy","year":"2005","journal-title":"Neurosurgery"},{"key":"B29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jocn.2007.05.014","article-title":"Elevation of neuron-specific enolase and S-100\u03b2 protein level in experimental acute spinal cord injury","volume":"15","author":"Cao","year":"2008","journal-title":"J Clin Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jnen\/59.4.287","article-title":"Cytoskeletal disruption following contusion injury to the rat spinal cord","volume":"59","author":"Zhang","year":"2000","journal-title":"J Neuropathol Exp Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1523\/JNEUROSCI.2568-14.2015","article-title":"Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats","volume":"35","author":"Hesp","year":"2015","journal-title":"J Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1097\/TA.0b013e318231bce7","article-title":"Neurological, functional, and biomechanical characteristics after high-velocity behind armor blunt trauma of the spine","volume":"71","author":"Zhang","year":"2011","journal-title":"J Trauma"},{"key":"B33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sc.2016.104","article-title":"Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury","volume":"55","author":"Moghaddam","year":"2017","journal-title":"Spinal Cord"},{"key":"B34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1742-2094-9-122","article-title":"Multiplex array proteomics detects increased MMP-8 in CSF after spinal cord injury","volume":"9","author":"Light","year":"2012","journal-title":"J Neuroinflam."},{"key":"B35","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.rvsc.2010.09.009","article-title":"Matrix metalloprotease-9 activity in the cerebrospinal fluid and spinal injury severity in dogs with intervertebral disc herniation","volume":"91","author":"Nagano","year":"2011","journal-title":"Res Vet Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/sj.sc.3102148","article-title":"TGF-\u03b21 and TGF-\u03b22 expression after traumatic human spinal cord injury","volume":"46","author":"Buss","year":"2008","journal-title":"Spinal Cord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/neu.2015.4294","article-title":"Tracking spinal cord injury: differences in cytokine expression of IGF-1, TGF- B1, and sCD95l can be measured in blood samples and correspond to neurological remission in a 12-week follow-up","volume":"34","author":"Ferbert","year":"2017","journal-title":"J Neurotr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0159764","DOI":"10.1371\/journal.pone.0159764","article-title":"Elevated serum insulin-like growth factor 1 levels in patients with neurological remission after traumatic spinal cord injury","volume":"11","author":"Moghaddam","year":"2016","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/sc.2012.139","article-title":"Increase in soluble CD95L during subacute phases after human spinal cord injury: a potential therapeutic target","volume":"51","author":"Biglari","year":"2013","journal-title":"Spinal Cord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/0300060514559794","article-title":"Serum sCD95L concentration in patients with spinal cord injury","volume":"43","author":"Biglari","year":"2015","journal-title":"J Int Med Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/sc.2015.28","article-title":"A pilot study on temporal changes in IL-1\u03b2 and TNF-\u03b1 serum levels after spinal cord injury: The serum level of TNF-\u03b1 in acute SCI patients as a possible marker for neurological remission","volume":"53","author":"Biglari","year":"2015","journal-title":"Spinal Cord"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.apmr.2007.08.004","article-title":"Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury","volume":"88","author":"Davies","year":"2007","journal-title":"Arch Phys Med Rehabil."},{"key":"B43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2015.04.004","article-title":"Tumor necrosis factor-alpha is a potential diagnostic biomarker for chronic neuropathic pain after spinal cord injury","volume":"595","author":"Xu","year":"2015","journal-title":"Neurosci Lett."},{"key":"B44","unstructured":"Analysis of serum pro-inflammatory cytokine levels after rat spinal cord ischemia\/reperfusion injury and correlation with tissue damage3539\n            HasturkA\n            AtalayB\n            CalisanellerT\n            OzdemirO\n            OruckaptanH\n            AltinorsN\n          19847755Turk Neurosurg.192009"},{"key":"B45","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/bies.10251","article-title":"Neurofilaments and neurological disease","volume":"25","author":"Al-Chalabi","year":"2003","journal-title":"BioEssays"},{"key":"B46","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.wneu.2013.03.012","article-title":"Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report","volume":"83","author":"Yokobori","year":"2015","journal-title":"World Neurosurg."},{"key":"B47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/neu.2013.3040","article-title":"Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein","volume":"31","author":"Diaz-Arrastia","year":"2014","journal-title":"J Neurotr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11011-016-9801-6","article-title":"Neuron specific enolase: a promising therapeutic target in acute spinal cord injury","volume":"31","author":"Haque","year":"2016","journal-title":"Metab Brain Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neures.2013.12.001","article-title":"Temporal-spatial expression of ENOLASE after acute spinal cord injury in adult rats","volume":"79","author":"Li","year":"2014","journal-title":"Neurosci Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/336674a0","article-title":"Selective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites","volume":"336","author":"Garner","year":"1988","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1073\/pnas.0601002103","article-title":"Structural insight into the role of myelin basic protein in multiple sclerosis","volume":"103","author":"Husted","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B52","volume-title":"Matrix Metalloproteinases and Neurotrauma: Evolving Roles in Injury and Reparative Processes","author":"Zhang","year":"2010"},{"key":"B53","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1097\/00001756-200011090-00029","article-title":"Metalloproteinase increases in the injured rat spinal cord","volume":"11","author":"de Castro","year":"2000","journal-title":"Neuroreport"},{"key":"B54","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/B978-0-12-385095-9.00225-6","article-title":"TGF-\u03b2","volume-title":"Handbook of Biologically Active Peptides","author":"Lifshitz","year":"2013"},{"key":"B55","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1523\/JNEUROSCI.0137-10.2010","article-title":"Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF- after vascular damage","volume":"30","author":"Schachtrup","year":"2010","journal-title":"J Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.tins.2011.06.002","article-title":"More than being protective: functional roles for TGF-\u03b2\/activin signaling pathways at central synapses","volume":"34","author":"Krieglstein","year":"2011","journal-title":"Trends Neurosci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/j.1460-9568.1997.tb01497.x","article-title":"Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study","volume":"9","author":"Bartholdi","year":"1997","journal-title":"Eur J Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1089\/neu.2005.22.919","article-title":"Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury","volume":"22","author":"Harrington","year":"2005","journal-title":"J Neurotr."},{"key":"B59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.apmr.2014.07.006","article-title":"Effect of long-term physical activity and acute exercise on markers of systemic inflammation in persons with chronic spinal cord injury: A systematic review","volume":"96","author":"Neefkes-Zonneveld","year":"2015","journal-title":"Arch Phys Med Rehabil."},{"key":"B60","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3041","article-title":"The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease","volume":"11","author":"Gleeson","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cca.2010.02.069","article-title":"Effect of exercise training on chronic inflammation","volume":"411","author":"Beavers","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B62","unstructured":"The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology4554\n            PhilippouA\n            MaridakiM\n            HalapasA\n            KoutsilierisM\n          17354613In Vivo212007"},{"key":"B63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.expneurol.2008.09.014","article-title":"IGF-I gene delivery promotes corticospinal neuronal survival but not regeneration after adult CNS injury","volume":"215","author":"Hollis","year":"2009","journal-title":"Exp Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0006-8993(97)00254-0","article-title":"Increase of interleukin-l\u03b2 mRNA and protein in the spinal cord following experimental traumatic injury in the rat","volume":"759","author":"Wang","year":"1997","journal-title":"Brain Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/11387","article-title":"Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury","volume":"5","author":"Springer","year":"1999","journal-title":"Nat Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3171\/jns.1998.89.6.0911","article-title":"Apoptosis after traumatic human spinal cord injury","volume":"89","author":"Emery","year":"1998","journal-title":"J Neurosurg."},{"key":"B67","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/cdd.2015.3","article-title":"The role of CD95 and CD95 ligand in cancer","volume":"22","author":"Peter","year":"2015","journal-title":"Cell Death Differ."},{"key":"B68","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00401-011-0882-3","article-title":"Fas\/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application","volume":"122","author":"Yu","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/sj.cdd.4401305","article-title":"CD95 ligand - death factor and costimulatory molecule?","volume":"10","author":"Janssen","year":"2003","journal-title":"Cell Death Differ."},{"key":"B70","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3171\/spi.2001.94.2.0257","article-title":"Presence and significance of CD-95 (Fas\/APO1) expression after spinal cord injury","volume":"94","author":"Zurita","year":"2001","journal-title":"J Neurosurg."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/01.BRS.0000129894.34550.48","article-title":"The role of Fas-mediated apoptosis after traumatic spinal cord injury","volume":"29","author":"Yoshino","year":"2004","journal-title":"Spine"},{"key":"B72","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3171\/2010.3.SPINE09190","article-title":"Glial scar and neuroregeneration: histological, functional, and magnetic resonance imaging analysis in chronic spinal cord injury","volume":"13","author":"Hu","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"B73","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nm1007","article-title":"Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury","volume":"10","author":"Demjen","year":"2004","journal-title":"Nat Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.wneu.2013.01.042","article-title":"Potential role of growth factors in the management of spinal cord injury","volume":"83","author":"Awad","year":"2015","journal-title":"World Neurosurg."},{"key":"B75","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.neuroscience.2005.07.064","article-title":"Changes in response to spinal cord injury with development: Vascularization, hemorrhage and apoptosis","volume":"137","author":"Whalley","year":"2006","journal-title":"Neuroscience"},{"key":"B76","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.C.O.;2-1","article-title":"Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury","volume":"53","author":"McTigue","year":"1998","journal-title":"J Neurosci Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.3892\/mmr.2015.3330","article-title":"Inhibition of monocyte chemoattractant peptide-1 decreases secondary spinal cord injury","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol Med Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/brain\/awh407","article-title":"Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1 and interleukin-1 in Wallerian degeneration","volume":"128","author":"Perrin","year":"2005","journal-title":"Brain"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1523\/JNEUROSCI.21-13-04649.2001","article-title":"MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord","volume":"21","author":"Ousman","year":"2001","journal-title":"J Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/jcb.10576","article-title":"Proteomics in biomarker discovery and drug development","volume":"89","author":"He","year":"2003","journal-title":"J Cell Biochem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.molonc.2014.03.006","article-title":"Mass spectrometry based biomarker discovery, verification, and validation - Quality assurance and control of protein biomarker assays","volume":"8","author":"Parker","year":"2014","journal-title":"Mol Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1074\/mcp.M116.058115","article-title":"Differential neuroproteomic and systems biology analysis of spinal cord injury","volume":"15","author":"Moghieb","year":"2016","journal-title":"Mol Cell Proteom."},{"key":"B83","doi-asserted-by":"publisher","first-page":"21607","DOI":"10.1038\/srep21607","article-title":"High-throughput proteomics reveal alarmins as amplifiers of tissue pathology and inflammation after spinal cord injury","volume":"6","author":"Didangelos","year":"2016","journal-title":"Sci Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.apmr.2014.08.003","article-title":"Impact of pressure ulcers on individuals living with a spinal cord injury","volume":"95","author":"Lala","year":"2014","journal-title":"Arch Phys Med Rehabil."},{"key":"B85","first-page":"38","article-title":"Recurrence of initial pressure ulcer in persons with spinal cord injuries","volume":"10","author":"Niazi","year":"1997","journal-title":"Adv Wound Care"},{"key":"B86","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1742-481X.2012.01002.x","article-title":"The average cost of pressure ulcer management in a community dwelling spinal cord injury population","volume":"10","author":"Chan","year":"2013","journal-title":"Int Wound J."},{"key":"B87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00002060-199603000-00004","article-title":"A new pressure ulcer risk assessment scale for individuals with spinal cord injury","volume":"75","author":"Salzberg","year":"1996","journal-title":"Am J Phys Med Rehabil."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1177\/147323000903700531","article-title":"The wound healing process: an overview of the cellular and molecular mechanisms","volume":"37","author":"Velnar","year":"2009","journal-title":"J Int Med Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/exmp.2002.2420","article-title":"Cellular and molecular alterations in spinal cord injury patients with pressure ulcers: a preliminary report","volume":"72","author":"Cruse","year":"2002","journal-title":"Exp Mol Pathol."},{"key":"B90","first-page":"413","article-title":"Evaluation of blood and serum markers in spinal cord injured patients with pressure sores","volume":"30","author":"Gurcay","year":"2009","journal-title":"Saudi Med J."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.apmr.2016.01.003","article-title":"Early detection of pressure ulcer development following traumatic spinal cord injury using inflammatory mediators","volume":"97","author":"Krishnan","year":"2016","journal-title":"Arch Phys Med Rehabil."},{"key":"B92","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.apmr.2012.10.037","article-title":"Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation","volume":"94","author":"DeJong","year":"2013","journal-title":"Arch Phys Med Rehabil."},{"key":"B93","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1464-410X.2006.06395.x","article-title":"The management of neurogenic bladder and quality of life in spinal cord injury","volume":"98","author":"Ku","year":"2006","journal-title":"BJU Int."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1089\/neu.2011.2226","article-title":"Wolfe and the spinal cord injury. the health and life priorities of individuals with spinal cord injury: a systematic review","volume":"29","author":"Simpson","year":"2012","journal-title":"J Neurotr."},{"key":"B95","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11934-011-0221-1","article-title":"Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management","volume":"12","author":"Sahai","year":"2011","journal-title":"Curr Urol Rep."},{"key":"B96","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ncpuro0521","article-title":"Management of detrusor\u2013external sphincter dyssynergia","volume":"3","author":"Ahmed","year":"2006","journal-title":"Nat Clin Pract Urol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.addr.2014.11.007","article-title":"Biomarkers of spinal cord injury and ensuing bladder dysfunction","author":"Cruz","year":"2015","journal-title":"Adv Drug Deliv Rev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.juro.2012.07.131","article-title":"Treatment of neurogenic stress urinary incontinence using an adjustable continence device: 4-year followup","volume":"188","author":"Mehnert","year":"2012","journal-title":"J Urol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.juro.2007.10.032","article-title":"Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup","volume":"179","author":"Giannantoni","year":"2008","journal-title":"J Urol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.3909\/riu0432","article-title":"Can urinary nerve growth factor be a biomarker for overactive bladder?","volume":"12","author":"Kuo","year":"2010","journal-title":"Rev Urol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/S0022-5347(06)00258-8","article-title":"Botulinum-a toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity","volume":"175","author":"Giannantoni","year":"2006","journal-title":"J Urol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/nau.22987","article-title":"Nerve growth factor does not seem to be a biomarker for neurogenic lower urinary tract dysfunction after spinal cord injury","volume":"36","author":"Krebs","year":"2017","journal-title":"Neurourol Urodyn."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T23:30:49Z","timestamp":1548718249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":102,"alternative-id":["10.3389\/fneur.2019.00027"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00027","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"article-number":"27"}}